Non-Invasive Monitoring Device Market Research Report - Forecast till 2030

Non-Invasive Monitoring Device Market: Information by Type (Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices and Blood Glucose Monitoring Devices), Modality (Table-Top Devices and Wearable Devices), Application (Cardiology, Neurology and Oncology), End User (Hospitals & Clinics, Diagnostic Centers, Research & Academic Institutes) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2030

ID: MRFR/MED/0977-CR | August 2019 | Region: Global | 204 Pages         

Non-Invasive Monitoring Device Market Speak to Analyst Request a Free Sample

Non-Invasive Monitoring Device Market Overview

Non-Invasive Monitoring Device market is projected to reach USD 20031.77 Million by 2030 at 5.20% CAGR during the forecast period 2022-2030.

Patient monitoring is a crucial job in the medical field. The monitoring process helps to identify the underlying condition and recovery of the patient. Today, monitoring devices play a major role in the medical world. Three types of monitoring devices are minimally invasive, non-invasive and invasive. The mechanism of these devices is unique. The non-invasive monitoring device market segment is witnessing high profits. The monitoring devices do not require penetration into the human body. These advantages of the non-invasive monitoring device increase its demand. 

It can generate and provide results of accurate body readings. The applications of the non-invasive medical device are pulse oximetry, Bp measurement, electrocardiogram and balder temperature checking. It is an essential monitoring system to identify the conditions such as cardiac disorder and cancer. Also, the diabetes type 2 non-invasive monitoring devices are popular these days. The requirement for these non-invasive monitoring is rising at a rapid pace at the forecast period. The non-invasive monitoring device market growth is estimated at 6.80%. Also, the non-invasive monitoring device market value is assumed to be 21,586.2 Million. The demand for non-invasive is more than the demand for invasive monitoring is massive in 2023. 

Covid analysis 

Covid 19 has caused unexpected changes in the non-invasive monitoring device market. However, the medical industry is facing massive demand during this period. The rising demand for medical devices and technology is at its peak. The Non-invasive Blood Glucose Monitoring Devices Market is witnessing exceptional growth opportunities.

The requirement of the non-invasive monitoring systems health blood is high. The supply of non-invasive health monitor has been increased to meet immense market demand. The non-invasive monitoring device is also used in the covid critical care centres. It is helpful to monitor the patients and their recovery from the coronavirus. Also, the significance of this technology is rising more in the future years. Further, even during the pandemic and post covid 19, the non-invasive monitoring device market trends remain steady. The crucial market players of the non-invasive monitoring device market are taking advantage of the current situation to earn more profits. All this contributes to a positive impact on the Non-invasive Blood Glucose Monitoring Devices Market. 

Non-Invasive Monitoring Device Market Size, by End User, 2016 (USD Million)    Non-Invasive Monitoring Device Market Source: MRFR Analysis

Market dynamics 

  • The crucial market drivers 

Non-invasive monitoring is high-end technology. Unlike any other medical devices, the awareness about this device is higher. The requirement of the blood monitoring system is massive in the medical industry. The blood monitoring devices are helpful to monitor the blood sugar levels of a diabetes patient.

Today, more than millions of individuals are suffering from diabetes. Also, the rate of diabetes patients is increasing every year. It is causing a serious need for non-invasive monitoring systems. The availability of non-invasive monitoring device both in public and private clinics are crucial Non-invasive Blood Glucose Monitoring Devices Market drivers. Furthermore, there are several initiatives by the government to reduce the rate of a diabetes patient. These initiatives ultimately raise the demand for monitoring devices. The immense population of diabetes patients in Asia and North America are another driving factor. 

  • The market growth opportunities 

Today, the use of invasive monitoring device is versatile. It is used for plenty of monitoring procedures. The speciality of this non-invasive device is the sensors. The device does require skin penetration. With the sensors, the device can provide the results of the patient. The hassle-free properties of the device offer plenty of future scopes. Also, there are varieties such as the brain, cardiac, blood, anesthesia and neurology non-invasive monitoring devices. The prevalence of people having these disorders is increasing. It is creating future growth opportunities for the non-invasive monitoring market.

Furthermore, in the upcoming years, technological advancement in the healthcare sector is massive. The adoption rate of these technologies also rises ever higher. The awareness and requirement of the monitoring devices provide exceptional growth opportunities. Also, the new developments in non-invasive devices will fuel the Non-invasive Blood Glucose Monitoring Devices Market growth. The new methods of non-invasive monitoring of intracranial pressure (ICP) are the future developments. 

  • The market restraints 

The non-invasive monitoring device is sophisticated. The complexity of this medical device is a crucial restraint to the market. The adoption rate of this technology lows down due to device complexity. The readings of the non-invasive device are known as erroneous. It confuses while using the device in the healthcare sector. The wearable device is easier to operate than invasive monitoring devices.

However, there is a lack of awareness about its easy functions and benefits. These aspects are the most crucial restraining factors of the market. Also, the use of non-invasive monitoring device requires the approval of the government. However, in several regions, there are stringent government norms regarding the use. It is causing several restrictions in the overall non-invasive monitoring device market growth. 

  • The market challenges 

The non-invasive monitoring device is a crucial part of developed countries medical infrastructure. However, the device is not a part of several healthcare centres in undeveloped regions. The requirement of these drives is high in the underdeveloped region. However, the awareness about the device is less in underdeveloped areas. It is causing several inconsistencies in the non-invasive monitoring device market.

The lack of awareness in undeveloped regions is a significant challenge of the market. There are several drawbacks due to this challenge. It restricts the non-invasive monitoring device market in the future years. Also, the non-invasive monitoring device industry requires more R&D for new developments. The non-invasive monitoring device market can survive better with the help of new development. Therefore, the significant market challenge is the lack of awareness in underdeveloped regions and fewer new developments. 

  • Cumulative growth analysis 

The non-invasive monitoring device market is a flourishing market. The need for this device is growing at an exponential pace. There are plenty of drivers that propel the non-invasive monitoring device market growth. Also, there are plenty of potential growth opportunities that provide exceptional prospect. However, some factors hamper overall growth. The complexity in the device operations is a restraint. Also, the exposure of the non-invasive monitoring device is less in the underdeveloped regions. These factors can decline the on-invasive monitoring device industry demand in future years. However, the non-invasive monitoring device industry growth remains steady amidst all these factors. The new strategies of the key market players help in eliminating the challenges. Therefore, the cumulative growth analysis of the non-invasive monitoring device market is positive. 

  • Value chain analysis 

North America holds the largest non-invasive monitoring device market share. The rate of diabetes patients is high in this region. The well-known segments are the neurodiagnostic and monitoring devices market in us. The demand in this region will intensify in the upcoming years. Also, the technology adoption rate is immense in North America.

Moreover, the expenditure on medical devices is higher than in any countries. The investments rate on Non-invasive monitoring device is massive in North America. All these aspects contribute to the overall market growth in this region. The governmental initiatives to promote the product are another on-invasive monitoring device industry driver. Non-invasive monitoring health biomarkers are surging in North America. Also, North America will be the highest contributing non-invasive monitoring device market. 

Market segments 

By type 

  • Cardiac monitors 

  • Blood pressure monitor 

  • Anaesthesia monitor 

  • Elecrtocardiagroh monitor 

  • Brain monitor 

  • Blood gluacose monitor 

By Model 

  • Wearable device 

  • Tabletop device

 By application 

  • Oncology

  • Cardiology

  • Neurology

By region 

North America 

  • South America

  • US 

  • Canada 


  • Spain 

  • Germany 

  • Italy 

  • France 

  • UK 

Middle east 

  • Qatar 

  • Arabia 

  • Oman 

  • Kuwait 

Asia pacific 

  • India 

  • South Korea 

  • China 

  • Japan 

  • Australia 

Regional analysis 

The non-invasive monitoring device is fragmented into North America, Asia Pacific, Middle East and Europe. North America holds its dominance during the forecast period. The Asia Pacific is known as the fastest-growing non-invasive monitoring device market. The prevalence of diabetes and cardio disorders is the crucial non-invasive monitoring device market drivers in this region. The increasing diabetes population in India is propelling the non-invasive monitoring device market growth.

Further, the approval of non-invasive monitoring device by the government is increasing market growth in Europe. The non-invasive monitoring device market in Europe has well-established players. The Middle East regions are another developing market. The share acquisitions are lower but the market growth is higher. There is plenty of awareness about non-invasive monitoring device in all these regions. The adoption rate is also higher in these regions. All these contribute to the high demand in this region. 

Competitive landscape 

The non-invasive monitoring device market is highly competitive. The demand is immense in the key regions. The launch of new development in this non-invasive monitoring device market is causing more demand. The adoption rate of the wearable monitoring device is higher during the forecasts period. 

The key players of the non-invasive, invasive monitoring are 

  • Advanced Brain Monitoring

  • General Electric

  • medical

  • Medtronic

  • CNSystems Medizintechnik 

  • Philips

  • Integrity Applications

  • OrSense

  • Abbott

  • Tensys Medical

  • Omron

  • A&D Medical

  • Vaso Corporation

  • CAS Medical Systems

Recent developments 

  1. The US market has launched the C pro 6 non-invasive monitoring device. The new device was developed for diabetes patient. The system is suitable for diabetes patients above the age of 2 years.  

  1. The key players of the market are conspiring plans to improve their product offering. It assures that there is going to be plenty of future developments.  

  1. The US market is introducing the GLUCOCARD monitoring device. It is specially developed for blood glucose monitoring applications. 

Report overview 

  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments

Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 20031.77 Million
  CAGR   5.20% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Modality, Application, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Advanced Brain Monitoring, General Electric, medical, Medtronic, CNSystems Medizintechnik, Philips, Integrity Applications, OrSense, Abbott, Tensys Medical Omron, A&D Medical, Vaso Corporation, CAS Medical Systems
  Key Market Opportunities

  • The prevalence of people having these disorders is increasing
  • Technological advancement in the healthcare sector
  • The awareness and requirement of the monitoring devices
  •   Key Market Drivers

  • The requirement of the blood monitoring system
  • The availability of non-invasive monitoring device
  • Several initiatives by the government to reduce the rate of a diabetes patient
  • The immense population of diabetes patients

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Non-invasive monitoring device market projected to grow at approximately 5.20% CAGR during the assessment period (2022-2030).

    The valuation of the non-invasive monitoring device market is estimated to increase to USD 20031.77 Million by the end of 2030.

    Favorble reimbursement policies and the presence of numerous private & government-backed insurance firms, are major tailwinds pushing the growth of the non-invasive monitoring device market.

    North America holds the largest share in the non-invasive monitoring device market, followed by the Asia Pacific and Europe, respectively.

    Medtronic Plc., Advanced Brain Monitoring, Inc., General Electric Company, NIMedical, Koninklijke Philips N.V, Omron Corporation, CNSystems Medizintechnik AG, Abbott, Vaso Corporation, Tensys Medical Inc., CAS Medical Systems, Inc., OrSense Ltd., Integrity Applications, and A&D Medical Inc., are some of the top players operating in the non-invasive monitoring device market.

    Global Non-Invasive Monitoring Device Market: Competitive Landscape

    KONINKLIJKE PHILIPS N.V, Medtronic plc, Omron Corporation, General Electric Company, and Abbott collectively accounted for more than 32% share of the global non-invasive monitoring device market in 2016. These companies continue to maintain their strong global presence through expansions, mergers & acquisitions, and extensive product portfolios.

    In 2016, KONINKLIJKE PHILIPS N.V was the leading player in the market. The company pursued a strategy of product and technology innovation in close collaboration with the end-users by focusing on specialties and system solutions. The company leverages its expertise to develop new technologies and products. This is in line with its strategy of optimizing its product portfolio and structures. The company, particularly, has a strong foothold in North America and Europe - two of the most important markets for non-invasive monitoring device. Their dominance is likely to remain unchallenged during the assessment period.

    In 2016, Medtronic plc held the second position in terms of market share. The company is the world's largest standalone medical equipment development company and follows the strategy of launching new products and focuses on the acquisition and collaboration with an aim to minimize the competition. For instance, in 2015, the company acquired Surgical Solutions division of RF Surgical Systems, Inc.

    Omron Corporation occupies the third spot in the market. The company is well known for medical equipment such as digital thermometers, blood pressure monitors, and nebulizers. The company’s healthcare segment accounted for 13.1% of its total revenue in 2016. Omron Corporation offers upper arm blood pressure monitors and wrist blood pressure monitors in the market. Moreover, the organization is expected to increase its revenue by expanding the markets to the developing region and provide cost-effective products to the users.

    General Electric Company is one of the leading companies in the global non-invasive monitoring device market. The company sees its key strategy as focusing on creating strong product portfolio, cost reduction, and delivering best-in-class client experience. In 2016, the healthcare segment of the company generated 15% of its revenue.

    In 2016, Abbott held the fifth position in the global market. The company offers a wide range of products in pharmaceuticals, medical devices, diagnostics, and nutrition categories and majorly operates within the U.S. The company emphasizes on product diversity enhancement, acquisitions, and collaborations for expanding its reach in the developing markets. For instance, in August 2017, the company received the US FDA approval for Insertable Cardiac Monitor, which is the world's first smartphone compatible ICM designed with an aim to help physicians in remotely identifying cardiac arrhythmias.

    New product developments are a key focus area for players as the demand for more effective products continues to grow. In the near future, market players are also likely to be benefited from the policies that are being introduced by governments in developing countries for healthcare improvement. The introduction of favorable legislation for the healthcare sector has encouraged players to increase their investment in these countries. Companies continue to emphasize on adoption of new growth strategies to gain a greater foothold in the market on a global level.